Kauppinen R, Sintonen H, Vilkka V, Tukiainen H
South Karelia Central Hospital, Lappeenranta, Finland.
Respir Med. 1999 Apr;93(4):283-9. doi: 10.1016/s0954-6111(99)90026-4.
Patient education and self-management programmes have proved effective in many studies with short follow-up periods. We studied the 3-year cost-effectiveness of an intensive programme of patient education and supervision for self-management. The study consisted of 162 consecutive newly diagnosed asthmatics who were randomized either into an intervention group (IG) receiving intensive patient education and supervision for self-management at an outpatient clinic during the first year, or a control group (CG) receiving conventional education at the baseline visits only. Both groups had 2 additional years of follow-up. Lung functions and health-related quality of life (HRQOL) were measured. Extra direct and indirect costs were recorded. At 3 years the differences in forced expiratory volume in 1 s (FEV1) and in peak expiratory flow (PEF) were significantly better in the IG being in (% predicted) respectively 5.3 (95% CI 0.6-10.0) and 4.4 (95% CI 0.1-8.7), (P < 0.05). The airway responsiveness (PD15) did not differ significantly, but the improvement from baseline to 3 years was significantly greater in the IG, being 0.40 dose steps (95% CI 0.05-0.75) (P < 0.05). HRQOL scores did not differ significantly. The risk for sickness day was less in the IG with a RR of 0.6 (95% CI 0.50-0.69) (P = 0.000) and among patients who used the PEF meter. The compliance was similar in both groups when measured by the PEF-based self-management. There was no statistically significant difference in costs, although there was a consistent tendency for lower costs in the intensive programme. The intensive programme was more effective in terms of FEV1, PEF and improvement in PD15 and equally effective in terms of other lung functions and HRQOL, but there was no clear difference in the costs.
患者教育与自我管理项目在许多短期随访研究中已被证明是有效的。我们研究了一项强化患者教育与自我管理监督项目的3年成本效益。该研究纳入了162例连续的新诊断哮喘患者,他们被随机分为干预组(IG)和对照组(CG)。干预组在第一年在门诊接受强化患者教育与自我管理监督,对照组仅在基线访视时接受常规教育。两组均进行了另外2年的随访。测量了肺功能和健康相关生活质量(HRQOL)。记录了额外的直接和间接成本。3年后,干预组1秒用力呼气量(FEV1)和呼气峰值流速(PEF)的差异明显更好,分别为(预测值百分比)5.3(95%CI 0.6 - 10.0)和4.4(95%CI 0.1 - 8.7),(P < 0.05)。气道反应性(PD15)无显著差异,但从基线到3年的改善在干预组中明显更大,为0.40剂量步长(95%CI 0.05 - 0.75)(P < 0.05)。HRQOL评分无显著差异。干预组患病天数风险较低,相对危险度为0.6(95%CI 0.50 - 0.69)(P = 0.000),在使用PEF仪的患者中也是如此。通过基于PEF的自我管理测量,两组的依从性相似。成本方面无统计学显著差异,尽管强化项目的成本有持续降低的趋势。强化项目在FEV1、PEF和PD15改善方面更有效,在其他肺功能和HRQOL方面同样有效,但成本方面无明显差异。